Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$535,811,571
+$140,025,136 QoQ
Shares Held
11,176,712
+3.8% QoQ
Ownership
0.253%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $41,356,581,132 across 16 Drug Manufacturers - General names. NVO ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,274,243 | $13,522,666,405 | |
| 2 | JNJ |
Johnson & Johnson
|
23,438,141 | $5,952,584,668 | |
| 3 | ABBV |
AbbVie Inc.
|
21,237,764 | $5,344,270,929 | |
| 4 | MRK |
Merck & Co., Inc.
|
30,535,208 | $3,923,774,226 | |
| 5 | AZN |
Astrazeneca PLC
|
17,690,462 | $3,354,465,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,649,065 | $2,356,122,869 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,045,352 | $1,961,693,176 | |
| 8 | AMGN |
Amgen Inc
|
5,058,830 | $1,831,903,515 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $535,811,571 | 11,176,712 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $395,786,435 | 10,769,699 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $603,850,400 | 11,868,129 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $743,753,442 | 13,403,378 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,016,076,408 | 14,721,478 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,027,199,807 | 14,792,624 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,332,654,868 | 15,492,384 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,705,847,899 | 14,326,429 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,025,389,671 | 14,189,363 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,676,099,058 | 13,053,731 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,342,306,057 | 12,975,409 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,162,331,873 | 12,781,305 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,008,044,246 | 6,229,032 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,006,177,766 | 6,322,595 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $915,339,063 | 6,763,256 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $729,454,592 | 7,321,636 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $832,022,402 | 7,466,772 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $826,279,627 | 7,440,609 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $819,187,152 | 7,314,171 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $716,369,587 | 7,461,406 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $611,893,774 | 7,304,450 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $505,335,348 | 7,495,333 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $528,045,112 | 7,559,701 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $550,576,287 | 7,929,948 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $516,542,774 | 7,888,558 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $630,644,903 | 10,475,829 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||